Perrigo Has Approval For Copy Of OTC Voltaren Arthritis Relief Before GSK Launches The Brand

Perrigo will launch generics of GSK's OTC Voltaren Arthritis Pain drug later in 2020 following FDA approval of its ANDA. GSK, which received FDA's OTC switch approval in February, still hasn't launched the product or indicated when it will.

Business Concept As A Full-Energy Businessman Running On Track To Get Through Red Ribbon As Finish Line. It Means Performing The Best Effort To Succeed The Goal And Overcome Difficulty Ahead.

Perrigo Co. PLC often is first to launch a generic version of an OTC switch, but the firm might have notched a new first by gaining US approval for a copy of Voltaren Arthritis Pain topical before GlaxoSmithKline PLC launched it.

Dublin-based Perrigo on 6 April announced the Food and Drug Administration approved its abbreviated new drug application for OTC diclofenac...